Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maya Berg

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|February 4, 2015
Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptationsMaya Berg, Raquel García-Hernández, Bart Cuypers, et al.
Molecular Microbiology|September 12, 2013
Metabolic adaptations of Leishmania donovani in relation to differentiation, drug resistance, and drug pressureMaya Berg, Manu Vanaerschot, Andris Jankevics, et al.
Plos One|July 26, 2017
Macromolecular biosynthetic parameters and metabolic profile in different life stages of Leishmania braziliensis: Amastigotes as a functionally less active stageMarlene Jara, Maya Berg, Guy Caljon, et al.
Frontiers in Oncology|December 6, 2021
ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal AdenocarcinomaFarnaz Sedigheh Takhsha, Christel Vangestel, Muhammet Tanc, et al.
Chemmedchem|August 28, 2010
α-ketoheterocycles as inhibitors of Leishmania mexicana cysteine protease CPBKoen Steert, Maya Berg, Jeremy C Mottram, et al.
Journal of Extracellular Vesicles|March 17, 2025
Human Transmembrane Serine Protease 2 (TMPRSS2) on Human Seminal Fluid Extracellular Vesicles Is Proteolytically ActiveEmile Verhulst, Michelle De Bruyn, Pascale Berckmans, et al.
Journal of Medicinal Chemistry|February 6, 2025
Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System DiseasesCamilla Scarpellini, Greta Klejborowska, Caroline Lanthier, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
Design and evaluation of Trypanosoma brucei metacaspase inhibitorsMaya Berg, Pieter Van der Veken, Jurgen Joossens, et al.
Journal of Medicinal Chemistry|January 26, 2026
Vectorized ULK1/2 and VPS34 Inhibitors for Tissue-Selective Autophagy Inhibition in OncologyLorenzo Cianni, Kathryn Jacobs, Sergei Grintsevich, et al.
International Journal of Molecular Sciences|October 13, 2021
Proteolytic Cleavage of Bioactive Peptides and Protease-Activated Receptors in Acute and Post-ColitisMichelle De Bruyn, Hannah Ceuleers, Nikita Hanning, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|February 4, 2015
Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptationsMaya Berg, Raquel García-Hernández, Bart Cuypers, et al.
Molecular Microbiology|September 12, 2013
Metabolic adaptations of Leishmania donovani in relation to differentiation, drug resistance, and drug pressureMaya Berg, Manu Vanaerschot, Andris Jankevics, et al.
Plos One|July 26, 2017
Macromolecular biosynthetic parameters and metabolic profile in different life stages of Leishmania braziliensis: Amastigotes as a functionally less active stageMarlene Jara, Maya Berg, Guy Caljon, et al.
Frontiers in Oncology|December 6, 2021
ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal AdenocarcinomaFarnaz Sedigheh Takhsha, Christel Vangestel, Muhammet Tanc, et al.
Chemmedchem|August 28, 2010
α-ketoheterocycles as inhibitors of Leishmania mexicana cysteine protease CPBKoen Steert, Maya Berg, Jeremy C Mottram, et al.
Journal of Extracellular Vesicles|March 17, 2025
Human Transmembrane Serine Protease 2 (TMPRSS2) on Human Seminal Fluid Extracellular Vesicles Is Proteolytically ActiveEmile Verhulst, Michelle De Bruyn, Pascale Berckmans, et al.
Journal of Medicinal Chemistry|February 6, 2025
Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System DiseasesCamilla Scarpellini, Greta Klejborowska, Caroline Lanthier, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
Design and evaluation of Trypanosoma brucei metacaspase inhibitorsMaya Berg, Pieter Van der Veken, Jurgen Joossens, et al.
Journal of Medicinal Chemistry|January 26, 2026
Vectorized ULK1/2 and VPS34 Inhibitors for Tissue-Selective Autophagy Inhibition in OncologyLorenzo Cianni, Kathryn Jacobs, Sergei Grintsevich, et al.
International Journal of Molecular Sciences|October 13, 2021
Proteolytic Cleavage of Bioactive Peptides and Protease-Activated Receptors in Acute and Post-ColitisMichelle De Bruyn, Hannah Ceuleers, Nikita Hanning, et al.
Pageof 4